Sharmila Dorbala
#166,692
Most Influential Person Now
Researcher
Sharmila Dorbala's AcademicInfluence.com Rankings
Sharmila Dorbalaengineering Degrees
Engineering
#7400
World Rank
#8771
Historical Rank
Biomedical Engineering
#745
World Rank
#757
Historical Rank
Sharmila Dorbalaphilosophy Degrees
Philosophy
#9841
World Rank
#13455
Historical Rank
Logic
#6799
World Rank
#8348
Historical Rank
Download Badge
Engineering Philosophy
Sharmila Dorbala's Degrees
- Doctorate Medicine Harvard University
Why Is Sharmila Dorbala Influential?
(Suggest an Edit or Addition)Sharmila Dorbala's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis (2016) (1108)
- Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve (2011) (683)
- Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. (2012) (539)
- Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. (2013) (490)
- Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes (2014) (435)
- Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus (2012) (411)
- ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures (2016) (389)
- Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization (2015) (379)
- AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. (2016) (375)
- Interrelation of Coronary Calcification, Myocardial Ischemia, and Outcomes in Patients With Intermediate Likelihood of Coronary Artery Disease: A Combined Positron Emission Tomography/Computed Tomography Study (2008) (362)
- Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction (2018) (312)
- Clinical Myocardial Perfusion PET/CT* (2007) (282)
- FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC (2018) (278)
- Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. (2019) (261)
- Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. (2007) (254)
- Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET (2009) (247)
- Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. (2009) (243)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging (2019) (235)
- Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography (2014) (235)
- Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study. (2018) (220)
- Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease (2017) (208)
- Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis (2014) (208)
- Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. (2013) (203)
- Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation (2018) (203)
- Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. (2007) (200)
- Preserved Coronary Flow Reserve Effectively Excludes High-Risk Coronary Artery Disease on Angiography (2014) (200)
- Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. (2007) (196)
- SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0* (2013) (180)
- Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring (2017) (174)
- Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging (2007) (174)
- Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring (2017) (164)
- Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2017) (157)
- Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease (2017) (156)
- Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation (2017) (154)
- Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). (2012) (152)
- Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis (2018) (146)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI EXPERT CONSENSUS RECOMMENDATIONS FOR MULTIMODALITY IMAGING IN CARDIAC AMYLOIDOSIS: PART 1 OF 2-EVIDENCE BASE AND STANDARDIZED METHODS OF IMAGING. (2019) (141)
- Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. (2014) (141)
- Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2017) (141)
- Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease (2015) (129)
- A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology (2018) (127)
- Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. (2012) (122)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization (2019) (121)
- Isolated cardiac sarcoidosis: A focused review of an under-recognized entity (2018) (119)
- Patient-centered imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. (2014) (118)
- International Impact of COVID-19 on the Diagnosis of Heart Disease (2021) (112)
- How to Image Cardiac Amyloidosis: A Practical Approach. (2020) (109)
- How to image cardiac amyloidosis. (2014) (109)
- Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study (2018) (102)
- Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. (2011) (101)
- Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. (2019) (99)
- Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. (2013) (99)
- Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. (2020) (96)
- Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. (2015) (93)
- Comparison of Fully Automated Computer Analysis and Visual Scoring for Detection of Coronary Artery Disease from Myocardial Perfusion SPECT in a Large Population (2013) (93)
- 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study (2015) (89)
- 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis (2013) (87)
- Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity (2008) (82)
- Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. (2013) (80)
- Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. (2018) (80)
- Coronary Circulatory Function in Patients with the Metabolic Syndrome (2011) (71)
- Does Radiofrequency Ablation Induce a Prethrombotic State? Analysis of Coagulation System Activation and Comparison to Electrophysiologic Study (1998) (69)
- Assessment of myocardial perfusion and function with PET and PET/CT (2010) (69)
- Cardiac PET perfusion: prognosis, risk stratification, and clinical management. (2014) (68)
- Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT) (2018) (67)
- Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI (2020) (65)
- Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy (2018) (65)
- Incremental Prognostic Value of Myocardial Perfusion Imaging in Patients Referred to Stress Single-Photon Emission Computed Tomography With Renal Dysfunction (2009) (63)
- 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT. (2020) (63)
- Prognostic value of PET myocardial perfusion imaging in obese patients. (2014) (61)
- Improved Accuracy of Myocardial Perfusion SPECT for the Detection of Coronary Artery Disease Using a Support Vector Machine Algorithm (2013) (61)
- Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis (2018) (61)
- Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. (2016) (61)
- Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-evidence and clinical recommendations (2017) (60)
- Effect of body mass index on left ventricular cavity size and ejection fraction. (2006) (60)
- A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology (2017) (59)
- Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes (2019) (58)
- Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. (2017) (57)
- Survey results: a decade of change in professional life in cardiology: a 2008 report of the ACC women in cardiology council. (2008) (57)
- 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis (2013) (57)
- State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis (2019) (56)
- Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry. (2019) (56)
- Recent advances in cardiac PET and PET/CT myocardial perfusion imaging (2009) (54)
- Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2018) (54)
- Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification. (1999) (53)
- Cardiac imaging. (2021) (53)
- Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. (2005) (53)
- Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic (2020) (50)
- Yield of downstream tests after exercise treadmill testing: a prospective cohort study. (2014) (47)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. (2019) (47)
- Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. (2005) (46)
- ACR Appropriateness Criteria® acute chest pain--suspected pulmonary embolism. (2012) (42)
- Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging (2009) (42)
- Integrated cardiac PET-CT for the diagnosis and management of CAD. (2006) (42)
- Multimodality imaging in the assessment of myocardial viability (2011) (41)
- Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). (2003) (41)
- Approaches to Reducing Radiation Dose from Radionuclide Myocardial Perfusion Imaging (2015) (39)
- Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner (2020) (39)
- ACR appropriateness criteria asymptomatic patient at risk for coronary artery disease. (2014) (38)
- Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies (2017) (38)
- Detection of Obstructive Coronary Artery Disease Using Regadenoson Stress and 82Rb PET/CT Myocardial Perfusion Imaging (2013) (38)
- Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT (2019) (37)
- Cardiac PET-CT (2007) (37)
- Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function (2017) (37)
- Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. (2020) (37)
- Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment (2019) (37)
- Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease (2006) (36)
- Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. (2019) (34)
- Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CT (2020) (33)
- Association of Electrocardiographic Morphology of Exercise-Induced Ventricular Arrhythmia with Mortality (2008) (33)
- Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. (2019) (32)
- Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. (2019) (32)
- Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery Disease. (2021) (32)
- Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership (2020) (31)
- Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? (2020) (31)
- Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test (2012) (30)
- Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. (2020) (29)
- Fully automated wall motion and thickening scoring system for myocardial perfusion SPECT: Method development and validation in large population (2012) (28)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. (2021) (28)
- Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI (2020) (28)
- Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. (2017) (27)
- Contemporary Cardiac SPECT Imaging—Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology (2018) (27)
- Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease? (2006) (27)
- Dose reduction in half-time myocardial perfusion SPECT-CT with multifocal collimation (2016) (26)
- Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. (2018) (26)
- Nuclear medicine services after COVID-19: gearing up back to normality (2020) (25)
- Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World (2021) (24)
- Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET (2014) (24)
- Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study (2019) (24)
- Myocardial perfusion imaging: Lessons learned and work to be done—update (2018) (24)
- Appropriate Use Criteria for PET Myocardial Perfusion Imaging (2020) (24)
- Quantitative measurement of sestamibi distribution to detect hidden ischemia made possible by application of Blumgart's method (2011) (21)
- Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia. (2020) (21)
- Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging (2006) (20)
- nAddendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. (2021) (19)
- Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging. (2004) (19)
- ACR Appropriateness Criteria chronic chest pain-low to intermediate probability of coronary artery disease. (2013) (18)
- Targeted Nuclear Imaging Probes for Cardiac Amyloidosis (2017) (18)
- Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging (2021) (18)
- Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis (2019) (18)
- Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation (2013) (18)
- Prognostic value of spect myocardial perfusion imaging in patients with elevated cardiac troponin i levels and atypical clinical presentation (2007) (17)
- Integrated PET/CT for cardiac imaging. (2006) (17)
- Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. (2021) (16)
- Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. (2015) (16)
- Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry (2019) (16)
- Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration. (2019) (16)
- Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. (2020) (16)
- Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. (2020) (15)
- Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry. (2019) (15)
- Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic (2020) (15)
- Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999-2016. (2019) (15)
- Effects of Gender on Coronary Microvascular Dysfunction and Cardiac Outcomes (2014) (15)
- Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry. (2021) (15)
- Coronary microvascular dysfunction in patients with psoriasis (2020) (14)
- Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI (2021) (14)
- Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registry (2019) (14)
- Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT (2021) (14)
- Integrated cardiac PET-CT for the diagnosis and management of CAD (2006) (14)
- Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe (2021) (14)
- Adding calcium scoring to myocardial perfusion imaging: Does it alter physicians’ therapeutic decision making? (2010) (13)
- Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease (2016) (13)
- Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy (2021) (13)
- Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS Registry. (2016) (13)
- Contemporary Cardiac SPECT Imaging-Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology. (2018) (12)
- Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET (2010) (12)
- Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 (2022) (12)
- Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population (2021) (11)
- Quantitative molecular imaging of cardiac amyloidosis: The journey has begun (2016) (11)
- Handling missing values in machine learning to predict patient-specific risk of adverse cardiac events: Insights from REFINE SPECT registry (2022) (11)
- Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) (2021) (11)
- The role of positron emission tomography in the evaluation of myocardial ischemia in women (2016) (11)
- Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. (2014) (11)
- Cardiovascular Nuclear Imaging: Balancing Proven Clinical Value and Potential Radiation Risk (2011) (10)
- Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans (2021) (10)
- Multimodality imaging of an unusual case of cardiac paraganglioma (2009) (10)
- ASNC Model Coverage Policy: Cardiac positron emission tomographic imaging (2013) (10)
- Joint SNMMI – ASNC Expert Consensus Document on the Role of 18 F-FDG PET / CT in Cardiac Sarcoid Detection and Therapy Monitoring Writing Group : (2017) (10)
- ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (ischemic cardiomyopathy already excluded). (2014) (10)
- Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. (2021) (10)
- ACUTE CHEST PAIN — SUSPECTED PULMONARY EMBOLISM (2013) (10)
- Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus (2021) (9)
- LEFT ATRIAL STRUCTURE AND FUNCTION OF THE AMYLOIDOGENIC V122I TRANSTHYRETIN VARIANT IN ELDERLY AFRICAN AMERICANS (2020) (9)
- The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis (2020) (9)
- The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types. (2020) (9)
- ASNC’s thoughts on the AHA/ACC chest pain guidelines (2021) (8)
- Quantitative Bone-Avid Tracer SPECT/CT for Cardiac Amyloidosis: A Crucial Step Forward. (2020) (8)
- Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging (2017) (8)
- Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity (2015) (8)
- Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis (2019) (8)
- Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging (2022) (8)
- Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. (2021) (8)
- Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) (2021) (8)
- Utility of multimodality imaging in diagnosis and follow-up of aortitis (2016) (7)
- The Impact of COVID-19 on Diagnosis of Heart Disease in Latin America an INCAPS COVID Sub-analysis. (2022) (7)
- Is There an Age When Myocardial Perfusion Imaging May No Longer Be Prognostically Useful? (2018) (7)
- Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging Protocols. (2021) (7)
- Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease (2019) (7)
- True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis (2018) (7)
- Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy (2021) (7)
- Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry (2020) (7)
- Selected review article based on ASNC meeting presentationIntegrated cardiac PET-CT for the diagnosis and management of CAD (2006) (6)
- Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis (2020) (6)
- A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging. (2020) (6)
- Guidance and Best Practices for Nuclear Cardiology Laboratories During the COVID-19 Pandemic (2020) (6)
- Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI (2020) (6)
- Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry (2021) (6)
- Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging. (2013) (6)
- DIAGNOSTIC VALUE OF TC99M SPECT MYOCARDIAL PERFUSION IMAGING IN COMPLEX CONGENITAL HEART DISEASE (2014) (5)
- Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis (2011) (5)
- Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging (2021) (5)
- Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery Disease (2022) (5)
- Acute Chest Pain — Suspected Aortic Dissection (2016) (5)
- Automated quantification and normal limits for myocardial perfusion stress/rest Rb-82 PET/CT (2009) (5)
- Diagnostic Accuracy of Deep Learning for Myocardial Perfusion Imaging in Men and Women with a High-Efficiency Parallel-Hole-Collimated Cadmium-Zinc-Telluride Camera: multicenter study (2020) (5)
- Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis. (2020) (5)
- A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. (2021) (5)
- Clinical Role of Hybrid Imaging (2010) (5)
- Quantitation of Poststress Change in Ventricular Morphology Improves Risk Stratification (2021) (5)
- Direct Risk Assessment From Myocardial Perfusion Imaging Using Explainable Deep Learning. (2022) (4)
- QT Dispersion and Viable Myocardium in Patients with Prior Myocardial Infarction and Severe Left Ventricular Dysfunction (2001) (4)
- Update on guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: Emphasis on transition to chronic endemic state. An information statement from ASNC, IAEA, and SNMMI (2022) (4)
- Do the ethnic differences in presentation and treatment strategy influence outcomes of contemporary percutaneous coronary intervention? A report from the national heart, lung, and blood institute dynamic registry (2003) (4)
- Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity (2016) (4)
- Molecular phenotyping of infiltrative cardiomyopathies: The future (2018) (4)
- Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. (2021) (4)
- V 1 Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82 Rb PET : Comparison with 13 N-Ammonia (2009) (4)
- Imaging of cardiac amyloidosis: Will this become a unique application for dual-isotope imaging? (2019) (4)
- Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". (2015) (4)
- Positron emission tomography for cardiac amyloidosis: Timing matters! (2021) (4)
- Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation (2020) (4)
- Coronary artery calcification and vascular function (2012) (4)
- Clinical value of hyperemic left ventricular systolic function in vasodilator stress testing (2017) (3)
- Changing the trajectory of ischemic heart disease in women: Role of imaging (2016) (3)
- DIAGNOSTIC ACCURACY OF ADVANCED IMAGING IN CARDIAC SARCOIDOSIS: AN IMAGING-HISTOLOGIC CORRELATION STUDY IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION (2019) (3)
- INTERACTION OF LEFT VENTRICULAR ISCHEMIA AND CORONARY VASOMOTOR DYSFUNCTION ON THE SURVIVAL BENEFIT OF REVASCULARIZATION AND MEDICAL THERAPY IN PATIENTS UNDERGOING STRESS MYOCARDIAL PERFUSION POSITRON EMISSION TOMOGRAPHY (2014) (3)
- 5-year Prognostic Value of Quantitative vs Visual Myocardial Perfusion Imaging in Subtle Perfusion Defects: Results From the REFINE SPECT Registry (2020) (3)
- Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images (2022) (3)
- Trends and Outcomes of Patients with Amyloid Cardiomyopathy Listed for Heart Transplantation. (2022) (3)
- Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. (2019) (3)
- Advancing the research mission of ASNC (2011) (3)
- Imaging cardiac amyloidosis: An opportunity for nuclear cardiology (2014) (3)
- Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis (2022) (3)
- Coronary vascular dysfunction and prognosis in patients age 75 and older (2012) (3)
- Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT (2019) (3)
- Correction to: Nuclear medicine services after COVID-19: gearing up back to normality (2020) (3)
- Utility of multimodality imaging in suspected prosthetic valve endocarditis (2016) (3)
- Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria (2019) (3)
- Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease (2018) (3)
- SPECT/CT quantification of lower limb perfusion: The next frontier in radionuclide perfusion imaging? (2020) (2)
- Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. (2014) (2)
- Transthyretin cardiac amyloidosis in patients with severe aortic stenosis. (2020) (2)
- Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry (2022) (2)
- Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer (2021) (2)
- Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure (2003) (2)
- Gender Differences in Radiation Dose from Nuclear Cardiology Studies Across the World : Findings from the International Atomic Energy Agency Nuclear Cardiology Protocols Study ( INCAPS ) Registry (2)
- Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy (2021) (2)
- Transthyretin Cardiac Amyloidosis in the Elderly-Tip of a Heart Failure Iceberg? (2021) (2)
- ASNC IMAGING GUIDELINES FOR NUCLEAR CARDIOLOGY PROCEDURES Instrumentation quality assurance and performance (2007) (2)
- Cardiac Sarcoidosis: Case Report, Workup, and Review of the Literature (2013) (2)
- 26.04—11:00 a.m.: Prognostic Value of Myocardial Perfusion Imaging in Patients with Impaired Renal Function (2007) (2)
- High Sensitivity Cardiac€Troponin T (2)
- Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia (2021) (2)
- Machine learning to predict abnormal myocardial perfusion from pre-test features (2022) (2)
- Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients (2021) (2)
- Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry (2021) (2)
- DIAGNOSTIC AND PROGNOSTIC UTILITY OF QUANTITATIVE CARDIAC PET EVALUATION OF CARDIAC ALLOGRAFT VASCULOPATHY (2016) (2)
- ASNC Statements of Principles on the Issue of Multimodality Imaging (2021) (2)
- Normal Variants and Pitfalls in Cardiac PET/CT. (2021) (2)
- Integrating semiquantitative measures of myocardial ischemia and quantitative coronary flow reserve assessed by 82Rubidium PET for the detection of multivessel coronary artery disease (2012) (2)
- Exercise Testing and Nuclear Scanning (2003) (2)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. (2021) (2)
- Abstract 13540: Non-Invasive Quantitative Assessment of Coronary Flow Reserve Improves Cardiac Risk Assessment in Patients with Diabetes (2011) (2)
- Analysis of the restoration of cardiology diagnostics scope in the Russian Federation during the COVID-19 pandemic: results of the Russian segment of the INCAPS COVID 2 study under the auspices of the International Atomic Energy Agency (2022) (1)
- Coronary microvascular function in cardiac amyloidosis (2012) (1)
- Advances in myocardial perfusion imaging. (2015) (1)
- Highlights of the 12th International Conference on Nuclear Cardiology and Cardiac CT (2015) (1)
- RELATIONSHIP OF CORONARY FLOW RESERVE WITH BODY MASS INDEX AND ADVERSE OUTCOMES IN PATIENTS WITHOUT OVERT ISCHEMIC HEART DISEASE: IMPLICATIONS FOR METABOLIC SURGERY ELIGIBILITY (2017) (1)
- PROGNOSTIC SIGNIFICANCE OF RESTING BLOOD PRESSURE AND BLOOD PRESSURE RESPONSE DURING VASODILATOR STRESS RB-82 POSITRON EMISSION TOMOGRAPHY MYOCARDIAL PERFUSION IMAGING (2015) (1)
- Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. (2014) (1)
- Myocardial Perfusion Imaging with PET (2007) (1)
- COMPARATIVE EFFECTIVENESS OF MYOCARDIAL PERFUSION SPECT AND CORONARY CT ANGIOGRAPHY FOR DIAGNOSIS OF CORONARY ARTERY DISEASE (2013) (1)
- Nuclear Imaging in Ischemic Heart Disease (2012) (1)
- Abstract 18193: Stress Myocardial Perfusion Positron Emission Tomography Provides Incremental Risk Prediction in Subjects With and Without Diabetes (2014) (1)
- Responsibility for follow-up of abnormal findings in myocardial perfusion imaging: A case-based ethics discussion (2015) (1)
- Prior SARS‐CoV‐2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography (2022) (1)
- Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis (2022) (1)
- How to approach an inappropriately ordered myocardial perfusion stress study: A case-based ethics discussion (2015) (1)
- Imaging cardiac amyloidosis: Patient page (2018) (1)
- Transmural perfusion: A new direction for myocardial blood flow (2022) (1)
- PREDICTING MAJOR ADVERSE CARDIAC EVENTS WITH COX NEURAL NETWORKS: RESULTS FROM THE REFINE SPECT REGISTRY (2019) (1)
- Abstract 17329: Prognostic Value of Coronary Flow Reserve in Patients with Prior Coronary Artery Bypass Surgery (2014) (1)
- Collegial pressure and patient-centered shared-decision making: A case-based ethics discussion (2015) (1)
- Abstract 14657: Intermuscular Fat is Independently Associated With Coronary Microvascular Dysfunction and Adverse Cardiovascular Outcomes in Patients With No Obstructive CAD (2020) (1)
- Effect of Concurrent Dementia on Heart Failure Hospital Outcomes: Nationwide Inpatient Sample (2007-2014). (2020) (1)
- Impact of the first wave of coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of heart disease in the Russian Federation: results from the IAEA Nuclear Cardiology Protocols Study (INCAPS) (2021) (1)
- Instrumentation quality assurance and performance (2007) (1)
- Abstracts of Original Contributions ASNC2019 The 24th Annual Scientific Session of the American Society of Nuclear Cardiology (2019) (1)
- ASNC Imaging Indications (ASNC-I2): Multisocietal indications for radionuclide imaging in the multimodality context—Series rationale and methodology (2021) (1)
- Abstract 15687: Myocardial Coronary Flow Reserve Predicts Adverse Clinical Outcomes Independently of Luminal Angiographic Score (2013) (1)
- Abstract 12921: Incremental Value of Noninvasive Cardiac Imaging in Risk Prediction: Results from the SPARC Study (2010) (1)
- Complexities and Pitfalls in Cardiac Amyloidosis. (2020) (1)
- CORONARY VASOMOTOR DYSFUNCTION, MYOCARDIAL INJURY AND DIASTOLIC DYSFUNCTION IN PATIENTS WITHOUT OVERT CORONARY ARTERY DISEASE (2014) (1)
- Abstracts of Original Contributions ASNC2022 The 27th Annual Scientific Session of the American Society of Nuclear Cardiology (2022) (1)
- Multimodality Imaging of Cardiac Amyloidosis (2015) (1)
- Geographic variation in public interest about amyloidosis in the United States and English speaking countries (2020) (1)
- SHORT-TERM TREATMENT WITH RANOLAZINE IMPROVES LEFT VENTRICULAR FILLING PRESSURES WITHOUT DETECTABLE CHANGES IN MYOCARDIAL BLOOD FLOW IN SYMPTOMATIC DIABETIC PATIENTS WITHOUT OBSTRUCTIVE CORONARY ARTERY DISEASE (2016) (1)
- 29Prognostic safety of automatic cancellation of rest myocardial perfusion scan by machine learning: a report from multicenter REFINE SPECT registry of new generation SPECT (2019) (1)
- Report of the ACC Women in Cardiology Council Survey Results: A Decade of Change in Professional Life in Cardiology: A 2008 (2008) (1)
- Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter Study (2022) (1)
- IMPAIRED CORONARY FLOW RESERVE IS ASSOCIATED WITH DIASTOLIC DYSFUNCTION AND HFPEF OUTCOMES IN PATIENTS WITHOUT OVERT CAD (2017) (1)
- Correlative imaging of spontaneous coronary artery dissection (2012) (1)
- Fibroblast Activation: A Novel Mechanism of Heart Failure in Light Chain Cardiac Amyloidosis? (2022) (1)
- Utility of multimodality imaging in myopericarditis with aortitis (2017) (1)
- EXERCISE TREADMILL TESTING HAS LOW UTILITY IN THE EVALUATION OF CORONARY MICROVASCULAR DISEASE (2019) (1)
- Nuclear cardiology in the information age (2020) (1)
- Apical to Base Gradient of Technetium-99m Pyrophosphate Myocardial Counts in Cardiac Amyloidosis: An Insight Into the Mechanism of Myocardial Strain Gradient, or Merely "Clouds That Mimic Land Before the Sailor's Eye?" (2017) (1)
- Recent clinical trials support continued emphasis on patient-first over modality-first approaches to initial test selection in patients with stable ischemic heart disease (2022) (1)
- A PILOT STUDY OF LEFT VENTRICULAR EJECTION FRACTION RESERVE DURING REGADENOSON RUBIDIUM-82 MYOCARDIAL PERFUSION IMAGING AND THE MAGNITUDE OF ISCHEMIA AND CAD (2010) (1)
- An antibody against pre-amyloid oligomers: a potential clinical tool or merely an intriguing observation? (2020) (1)
- (18)F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis? (2021) (0)
- Gender , microvascular dysfunction , and outcomes (2014) (0)
- Quantitation of Ventricular Morphology Provides Incremental Prognostic Utility in Patients Undergoing SPECT MPI (2020) (0)
- DEEP LEARNING APPROACH FOR AUTOMATED DETECTION OF CARDIAC AMYLOIDOSIS USING 99TC-PYP SPECT/CT (2022) (0)
- Letter by Falk et al Regarding Article, "False-Positive 99mTechnetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy". (2022) (0)
- Suspected Infective Endocarditis (2016) (0)
- Time and event-specific deep learning for personalized risk assessment after cardiac perfusion imaging (2023) (0)
- Editor's Note. (2017) (0)
- 6.1 Patients with dilated ventricles are more likely to have inferior wall attenuation artifacts (2001) (0)
- to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2— Evidence Base and Standardized Imaging Methods (2019) (0)
- PROGNOSTIC IMPACT OF DIABETES IN PATIENTS WITH OR WITHOUT KNOWN CORONARY ARTERY DISEASE, RESULTS FROM THE REFINE SPECT REGISTRY (2020) (0)
- ASSOCIATION BETWEEN PERICARDIAL FAT, CORONARY VASOREACTIVITY, AND OUTCOMES IN PATIENTS WITHOUT OVERT OBSTRUCTIVE CORONARY ARTERY DISEASE (2014) (0)
- Myocardial Perfusion Imaging with PET , PET / CT , PET / MRI : Technical Advances and Future Applications (0)
- Do the ACCF/ASNC appropriateness criteria predict outcomes in patients without known coronary artery disease? (2008) (0)
- Advancing the mission of cardiovascular molecular imaging (2021) (0)
- LESS OBSTRUCTIVE CORONARY ARTERY DISEASE, BUT NOT LESS DIFFUSE CORONARY ATHEROSCLEROTIC BURDEN IN WOMEN RELATIVE TO MEN REFERRED FOR CORONARY ANGIOGRAPHY (2015) (0)
- Abstract 16269: Decreased Skeletal Muscle, but Not Increased Fat is Independently Associated With Coronary Microvascular Dysfunction and Adverse Cardiovascular Outcomes (2019) (0)
- What is this image? 2018: image 6 result (2018) (0)
- AB0624 Patients with vasculitis have a high prevalence of coronary microvascular dysfunction (2022) (0)
- GLYCEMIA, CORONARY MICROVASCULAR DYSFUNCTION AND CARDIOVASCULAR RISK (2020) (0)
- Abstract 19019: Costs and Diagnostic Yield of Exercise Treadmill Testing vs. Exercise SPECT in Symptomatic Patients at Intermediate Risk of CAD (2014) (0)
- 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis. (2022) (0)
- RELATIONSHIP OF CORONARY VASOMOTOR FUNCTION TO MEAN RADIATION DOSE TO THE HEART IN CANCER SURVIVORS (2014) (0)
- Coronary vasomotor dysfunction is associated with worse outcomes in patients with inflammatory disease (2020) (0)
- Detection of Multiorgan Light Chain (AL) Amyloidosis with Whole Body F18-florbetapir PET/CT (2018) (0)
- 2021 SNMMI Highlights Lecture: Cardiovascular Track. (2022) (0)
- A letter to fellows in training. (2020) (0)
- PET and Integrated PET/CT Myocardial Imaging Protocols and Quality Assurance (2007) (0)
- Incremental prognostic value of quantitative coronary flow reserve compared to coronary calcium score in patients with normal stress semi-quantitative myocardial perfusion imaging (2011) (0)
- Quantitative PYP metrics: separating the wheat from the chaff. (2023) (0)
- P2769Nonalcoholic fatty liver disease: a marker of coronary microvascular dysfunction (2018) (0)
- P361 Assessment of accuracy and reproducibility of coronary flow reserve measured by SPECT in patients with known or suspected coronary artery disease (2020) (0)
- ANZSNM ASM 2021 Poster Presentations (2021) (0)
- SU-F-I-31: Reproducibility of An Automatic Exposure Control Technique in the Low-Dose CT Scan of Cardiac PET/CT Exams. (2016) (0)
- ACR Appropriateness Criteria(®) acute nonspecific chest pain-low probability of coronary artery disease. (2012) (0)
- Coronary Flow Reserve, Inflammation and Myocardial Strain in the Cardiovascular Inflammation Reduction Trial (CIRT-CFR) (2022) (0)
- SEX DIFFERENCES IN SUBENDOCARDIAL PERFUSION GRADIENT IN PATIENTS WITH HYPERTENSION (2023) (0)
- Abstract 21633: Relationship Between Descriptors of Coronary Atherosclerosis by Coronary Ct Angiography and Quantitative Myocardial Perfusion as Assessed by Hybrid PET/CT Imaging (2010) (0)
- Gated myocardial perfusion SPECT functional parameters predict functional recover after PTCA (1999) (0)
- Nuclear Cardiology (2023) (0)
- Social media in nuclear cardiology (2020) (0)
- Prognostic value of PET-derived coronary flow reserve for survival in patients with dialysis-dependent end-stage renal disease (2014) (0)
- Abstract 13679: Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography is Associated With Impaired Coronary Flow Reserve From Diffuse versus Obstructive Coronary Artery Disease (2015) (0)
- Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging (2012) (0)
- Patient Preparation and Stress Protocols for Cardiac PET and Integrated PET/CT Imaging (2007) (0)
- The new normal (2020) (0)
- The Role of Pet Scan in Stem Cell Therapy (2006) (0)
- Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis (2022) (0)
- What makes for a great editorial? The Ken Brown JNC Editorial Award (2022) (0)
- The Role of Pet Scan in Stem Cell Therapy (2006) (0)
- New technical developments in nuclear cardiology and hybrid imaging (2021) (0)
- Abstract 20041: Fully Automated Wall Motion and Thickening Scoring System for Myocardial Perfusion SPECT: Development and Validation in Large Population (2010) (0)
- Highlights of the 12th International Conference on Nuclear Cardiology and Cardiac CT. (2015) (0)
- INCREMENTAL PROGNOSTIC VALUE OF CORONARY FLOW RESERVE IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (2013) (0)
- Intermuscular Adiposity is Associated with Coronary Microvascular Dysfunction Independently of Body Mass Index and Modifies its Effect on Adverse Cardiovascular Outcomes (2023) (0)
- USE OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) FOR DIAGNOSING PROSTHETIC VALVE PERIVALVULAR ABSCESS (2017) (0)
- Quantifying the burden of cardiac amyloid: The future is about numbers! (2022) (0)
- Abstract 17672: Interaction of Global Coronary Vasomotor Dysfunction and Early Revascularization on Adverse Cardiovascular Outcomes (2014) (0)
- ASSOCIATION BETWEEN DETECTABLE CARDIAC TROPONIN, ABNORMAL MYOCARDIAL CORONARY FLOW RESERVE AND ADVERSE CLINICAL OUTCOMES IN PATIENTS WITHOUT OVERT CORONARY ARTERY DISEASE (2013) (0)
- Molecular Imaging of Cardiac Amyloidosis (2018) (0)
- INTEGRATING HYPEREMIC MYOCARDIAL BLOOD FLOW AND CORONARY FLOW RESERVE FOR PREDICTING CARDIOVASCULAR MORTALITY OUTCOMES IN PATIENTS WITH KNOWN OR SUSPECTED ISCHEMIC HEART DISEASE (2017) (0)
- PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS HAVE A HIGH PREVALENCE OF CORONARY MICROVASCULAR DYSFUNCTION IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE (2020) (0)
- Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. (2014) (0)
- Coronary Flow Reserve, Inflammation, and Myocardial Strain (2022) (0)
- Abstract 17099: Mortality From Heart Failure and Dementia in the United States: Centers for Disease Control (CDC) WONDER 1999 to 2015 (2017) (0)
- F18-florbetapir PET/CT imaging of cardiac amyloidosis: metabolite correction in compartmental modeling (2018) (0)
- CORONARY MICROVASCULAR DYSFUNCTION IS ASSOCIATED WITH SUBCLINICAL SYSTOLIC DYSFUNCTION AND HEART FAILURE ADMISSION IN HYPERTENSION (2020) (0)
- SERUM BIOMARKERS AND AMYLOID BURDEN BY LEFT VENTRICULAR EXTRACELLULAR VOLUME PREDICT ADVERSE OUTCOMES IN LIGHT CHAIN AMYLOIDOSIS (2022) (0)
- Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease. (2022) (0)
- Women leaders: transforming the culture in cardiology (2022) (0)
- Cases in Cardiac Sarcoidosis (2015) (0)
- IMPACT OF REFERRING PHYSICIAN SPECIALTY ON DOWNSTREAM TESTING AFTER EXERCISE TREADMILL TESTING (2013) (0)
- The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis. (2022) (0)
- Ask the doctor. I recently had a nuclear stress test and contrast agent got stuck in my gut, so the image couldn't be read. Is this a common problem, and is there anything that can be done about it? (2011) (0)
- Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization (2021) (0)
- Mitra-clip in Transthyretin Amyloidosis Cardiomyopathy A Case Series (2020) (0)
- High Sensitivity CardiacTroponin T (0)
- MYOCARDIAL SCAR BUT NOT ISCHEMIA PREDICTS DEFIBRILLATOR SHOCKS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION (2017) (0)
- Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now! (2023) (0)
- Impact of COVID-19 Pandemic on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (2021) (0)
- P4597Benefit of medical therapy versus revascularization in patients with stress myocardial perfusion single photon emission computed tomography: results from a large international registry (2018) (0)
- Cardiomyocyte stretch mediates the relation between left ventricular amyloid burden and adverse outcomes in light chain amyloidosis: a 18F-florbetapir positron emission tomography study (2022) (0)
- Abstract 13834: Low Coronary Microvascular Vasodilator Capacity Relative to Myocardial Mass Predicts Cardiovascular Risk in Hypertensive Heart Disease (2020) (0)
- Evaluating Prognosis in AL Amyloidosis (2020) (0)
- Nuclear Cardiology in 2023. (2023) (0)
- Progress in Cardiac Imaging Uncovers the Epidemiology of Wild-Type Transthyretin Amyloid Cardiomyopathy (2021) (0)
- Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis. (2023) (0)
- Abstracts of Original Contributions ASNC2013 The 18th Annual Scientific Session of the American Society of Nuclear Cardiology (2013) (0)
- CMR AND ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT VENTRICULAR STRAIN IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS (2019) (0)
- Impact of body mass index on CT dose-index reproducibility with automatic tube current modulation (2016) (0)
- IMPAIRED MYOCARDIAL FLOW RESERVE AND LEFT VENTRICULAR REMODELING IN AORTIC STENOSIS (2019) (0)
- Cardiac Hybrid Imaging (PET/CT and SPECT/CT): Assessment of CAD (2010) (0)
- A letter to fellows in nuclear cardiology (2020) (0)
- POST-EXERCISE HYPOTENSION: MARKER OF SIGNIFICANT CAD? (2015) (0)
- Is there a relationship between inflammatory biomarkers and coronary vasomotor function (2007) (0)
- FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: Joint procedural recommendation of the EANM, SNMMI, the PET Interest Group (PIG), and endorsed by the ASNC Writing group*: (2018) (0)
- Inflammatory and Infiltrative Diseases and Tumors (2015) (0)
- PROGNOSTIC VALUE OF CORONARY CTA VERSUS EXERCISE TREADMILL TESTING (2014) (0)
- CORONARY MICROVASCULARDYSFUNCTION IN PATIENTS WITH PSORISASIS (2020) (0)
- Abstract 13875: Non-Invasive Quantitative Assessment of Coronary Flow Reserve Improves Cardiac Risk Assessment in Patients with Renal Impairment (2011) (0)
- Impact of age, sex, and cardiac size on the diagnostic performance of myocardial perfusion single-photon emission computed tomography: insights from the REFINE SPECT registry (2021) (0)
- TRANSIENT ISCHEMIC DILATATION IS INDEPENDENTLY ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENTS IN PATIENTS WITHOUT ISCHEMIA: ANALYSIS OF THE REFINE REGISTRY (2019) (0)
- Abstract 2784: Quantitative Relation between Coronary Artery Calcium Content and Coronary Vasodilator Reserve as Assessed by Integrated PET-CT Imaging (2006) (0)
- ASSOCIATION BETWEEN CORONARY FLOW RESERVE AND ADVERSE CARDIOVASCULAR EVENTS ALONG A CONTINUUM OF METABOLIC DISEASE IN SYMPTOMATIC PATIENTS WITHOUT OVERT CORONARY ARTERY DISEASE (2017) (0)
- Changes in F18-flurodeoxyglucose uptake on serial cardiac positron emission tomography and left ventricular ejection fraction in patients with cardiac sarcoidosis (2013) (0)
- 2020: A Year of ASNC “Firsts” (2020) (0)
- Quantitative relation between coronary artery calcium and coronary vasodilator reserve assessed by integrated PET-CT imaging (2008) (0)
- The frequency of ischemia and clinical outcomes in asymptomatic patients with atrial fibrillation referred for myocardial perfusion imaging (2008) (0)
- Phenotyping of Cardiac Amyloidosis: Advancing From Macro to Micro? (2020) (0)
- Cardiology patient page. Exercise testing and nuclear scanning. (2003) (0)
- Transferring deep convolutional network representations from SPECT to improve PET cardiac outcome prediction (2023) (0)
- RELATIONSHIP OF SUBENDOCARDIAL PERFUSION TO MYOCARDIAL INJURY, LV REMODELING, AND CLINICAL OUTCOMES IN PATIENTS WITH HYPERTENSION (2023) (0)
- RESTING MYOCARDIAL BLOOD FLOW IS INVERSELY RELATED TO AMYLOID BURDEN IN LIGHT CHAIN CARDIAC AMYLOIDOSIS (2022) (0)
- Frontiers of Nuclear Cardiology. (2016) (0)
- MYO-PERICARDITIS WITH AORTITIS: UTILITY OF MULTI-MODALITY IMAGING (2015) (0)
- Imaging Cardiac Sarcoidosis, Amyloidosis, and Cardiovascular Prosthetic Infections (2021) (0)
- Abstracts of Original Contributions ASNC2017 The 22nd Annual Scientific Session of the American Society of Nuclear Cardiology (2017) (0)
- Myocardial Inflammation: Focus on Cardiac Sarcoidosis (2021) (0)
- GENDER EFFECTS ON CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE (2012) (0)
- CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS (2021) (0)
- Nuclear Imaging (SPECT and PET) in Cardiac Sarcoidosis (2015) (0)
- Abstract 15029: Impaired Hyperemic Myocardial Blood Flow is Associated With Subclinical Systolic Dysfunction and Myocardial Injury in Aortic Stenosis (2019) (0)
- CARDIAC MRI AND PET HAVE COMPLEMENTARY VALUE IN THE ASSESSMENT OF SUSPECTED CARDIAC SARCOIDOSIS (2016) (0)
- ASSOCIATION OF BASELINE MODEST ALCOHOL CONSUMPTION AND CORONARY MICROVASCULAR DYSFUNCTION IN THE CARDIOVASCULAR INFLAMMATION REDUCTION TRIAL (CIRT-CFR) (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sharmila Dorbala?
Sharmila Dorbala is affiliated with the following schools:
